Three doses of experimental sIPV of lot 1 at the schedule of 2,3,4 months of age
PRO-sIPV-3002
Phase 3 mab completed
Quick answer
Three doses of experimental sIPV of lot 1 at the schedule of 2,3,4 months of age for Poliomyelitis is a Phase 3 program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SINOVAC BIOTECH LTD
- Indication
- Poliomyelitis
- Phase
- Phase 3
- Modality
- mab
- Status
- completed